BRIDGET MARRIN: Open Payments
NPI 1376899450 · SAN GABRIEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,265 in 10 payments from 8 companies in 2025. Trend: 2023 $597 · 2024 $1,072 · 2025 $1,265
Food & beverage: $1,265
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $285 |
| GlaxoSmithKline, LLC. | 2 | $244 |
| Braeburn Inc. | 1 | $139 |
| Gilead Sciences, Inc. | 1 | $139 |
| Amgen Inc. | 1 | $123 |
| Lundbeck LLC | 1 | $121 |
| Syndax Pharmaceuticals, Inc. | 1 | $115 |
| Alnylam Pharmaceuticals Inc. | 1 | $99 |
Products named: REZDIFFRA, BRIXADI, EVENITY, SHINGRIX, OJJAARA, VYEPTI, REVUFORJ, GIVLAARI.
Industry payments across CA — which companies pay providers there.
